Position in ACRS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,150,701
+$3,816 QoQ
Shares Held
217,524
-28.9% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. ACRS ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in ACRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,150,701 | 217,524 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,146,885 | 305,836 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $920,903 | 305,948 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $587,702 | 309,317 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $456,980 | 321,817 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $483,577 | 316,064 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $652,111 | 262,948 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $351,686 | 305,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $343,985 | 312,714 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $387,641 | 312,614 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $360,175 | 343,024 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,533,143 | 369,802 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,938,546 | 379,802 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,555,893 | 192,323 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,030,678 | 192,424 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $918,476 | 58,353 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $838,884 | 60,092 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,091,274 | 63,299 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $986,960 | 67,879 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,229,004 | 68,278 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,132,233 | 64,478 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,624,845 | 64,478 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $372,025 | 57,500 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $153,390 | 59,685 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $112,808 | 69,635 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $72,420 | 69,635 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||